|
|
||||||||
Clinical Chemistry, Vol 29, 427-433, Copyright © 1983 by American Association for Clinical Chemistry
M Rosseneu, R Vercaemst, KK Steinberg and GR Cooper
Apolipoprotein B, the major protein component of very-low-density (VLDL) and low-density (LDL) lipoproteins in serum, is being widely measured in serum, to help assess risk of cardiovascular disease. Standardization has proven difficult because of the physical and immunochemical heterogeneity of LDL and VLDL, the masking of antigenic determinants of LDL and VLDL, the insolubility of apolipoprotein B, the instability of lipoprotein reference materials, and the multiplicity of analytical methods. Here we have examined the literature and collected current information from lipoprotein scientists to determine the problems--and the ways investigators have attempted to solve them--in preparation, storage, and use of standards and anti-apolipoprotein B sera, analytical procedures and reagents, and the nature of apolipoprotein B in serum. Standardization appears possible with development of stable reference materials that are applicable to the various analytical methods, controlled immunochemical reaction conditions, and establishment of a selected interim reference method for use as a point of reference.
The following articles in journals at HighWire Press have cited this article:
![]() |
Z. Jiang, S. Sun, A. Liang, W. Huang, and A. Qin Gold-labeled nanoparticle-based immunoresonance scattering spectral assay for trace apolipoprotein AI and apolipoprotein B. Clin. Chem., July 1, 2006; 52(7): 1389 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Chaves, J. T. Real, A. B. Garcia-Garcia, M. Civera, M. E. Armengod, J. F. Ascaso, and R. Carmena Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4926 - 4932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF] |
||||
![]() |
R. Carmena-Ramon, J. F. Ascaso, J. T. Real, J. M. Ordovas, and R. Carmena Genetic Variation at the ApoA-IV Gene Locus and Response to Diet in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1266 - 1274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |